BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7399626)

  • 1. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT; Share L; Wang BC; Shade RE
    Hypertension; 1980; 2(4):424-31. PubMed ID: 7399626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.
    Crofton JT; Share L; Shade RE; Lee-Kwon WJ; Manning M; Sawyer WH
    Hypertension; 1979; 1(1):31-8. PubMed ID: 544512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    Hypertension; 1987 Feb; 9(2):172-7. PubMed ID: 3818014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sodium, deoxycorticosterone and duration of hypertension on pressor responses in rats.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Physiol; 1982 Dec; 333():383-91. PubMed ID: 6763628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    Nicholas TE
    Br J Pharmacol; 1971 Jun; 42(2):179-92. PubMed ID: 4326321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin in the rat with partial nephrectomy-salt hypertension.
    Lee-Kwon WJ; Share L; Crofton JT; Shade RE; Brooks B; Muirhead EE; Manning M; Sawyer WH
    Clin Exp Hypertens (1978); 1981; 3(2):281-97. PubMed ID: 7215069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of vasopressin in the mechanism maintaining hypertension in the rat.
    Yazaki Y; Ohuchi Y; Ashida T; Saito T
    Jpn Circ J; 1981 Sep; 45(9):1116-20. PubMed ID: 7300021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension.
    Share L; Crofton JT; Ouchi Y
    Am J Med Sci; 1988 Apr; 295(4):314-9. PubMed ID: 3364463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Filep J; Frölich JC; Fejes-Toth G
    Clin Exp Hypertens A; 1985; 7(10):1457-70. PubMed ID: 3841034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of extracellular volume expansion in the development of DOC-salt hypertension in the rat.
    Villamil MF; Amorena C; Ponce-Hornos J; Müller A; Taquini AC
    Hypertension; 1982; 4(5):620-4. PubMed ID: 7106934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of vasopressin to hypertension.
    Share L; Crofton JT
    Hypertension; 1982; 4(5 Pt 2):III85-92. PubMed ID: 7049934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.